CSF2 and neoplasm: ONCOS-102 is a highly modified oncolytic adenovirus vector featuring a a 24-base pair deletion in the E1A region for selective replication in cells with a dysfunctional Rb pathway, and a GM-CSF transgene to enhance immune cell infiltration at the tumor site [147, 148].